Baroda BNP Paribas Mutual FundEquity Scheme - Small Cap Fund3 years
The Scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity related securities of small cap companies.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 4 Nov 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Prefer peers if · Prefer PGIM India Small Cap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Watch
3.0 years - usable, still building a track record.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
1.21% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -25.0%. Ask whether you can hold through a similar fall.
Vs category
Fail
0% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Paresh Jain · 0.3 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 30.0% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 25%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Date-aligned against NIFTY SMALLCAP 250 TRI. Capture ratios use common month-end observations through 5 Nov 2026.
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
1 Oct 2024 – 6 Aug 2026
Trough 28 Feb 2025 · recovered in 524 days
-25.0%
6 Feb 2024 – 24 Apr 2024
Trough 13 Mar 2024 · recovered in 42 days
-11.3%
11 Sept 2026 – open
Trough 23 Oct 2026 · not recovered
-10.0%
3 Jun 2024 – 10 Jun 2024
Trough 4 Jun 2024 · recovered in 6 days
-8.3%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
33
Vs category
44
Consistency
2
Risk-adjusted
47
Drawdown
38
Mean
33
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
No status reasons yet. History is still thin.
Supporting reads
No supporting reads in the current evidence set.
30 Sept 2026 · 63 holdings · top 10 are 30.0%.
Karur Vysya Bank Ltd
Financial
3.6%
Multi Commodity Exchange Of India Ltd
Financial
3.4%
Others CBLO
Unspecified
3.4%
Laurus Labs Ltd
Healthcare
3.2%
Navin Fluorine International Ltd
Materials
3.1%
DECISION
Status moved from MONITOR to HEALTHY.
27 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
21 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
19 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
16 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
24 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Sept 2026
DECISION
Status moved from REVIEW to MONITOR.
22 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
21 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
18 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
17 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
16 Sept 2026
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
PGIM India Mutual Fund
Bajaj Finserv Mutual Fund
Caveat: Lower trailing returns
Bandhan Mutual Fund
Caveat: Higher volatility
DSP Mutual Fund
Caveat: Deeper drawdown
Union Mutual Fund
Caveat: Deeper drawdown
Baroda BNP Paribas Mutual FundEquity Scheme - Small Cap Fund3 years
The Scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity related securities of small cap companies.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 4 Nov 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Prefer peers if · Prefer PGIM India Small Cap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Watch
3.0 years - usable, still building a track record.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
1.21% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -25.0%. Ask whether you can hold through a similar fall.
Vs category
Fail
0% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Paresh Jain · 0.3 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 30.0% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 25%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
4 Nov 2026 · +4.9% over 1Y
14.2819
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Date-aligned against NIFTY SMALLCAP 250 TRI. Capture ratios use common month-end observations through 5 Nov 2026.
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
4 Nov 2026
-4.4%
1 Oct 2024 – 6 Aug 2026
Trough 28 Feb 2025 · recovered in 524 days
-25.0%
6 Feb 2024 – 24 Apr 2024
Trough 13 Mar 2024 · recovered in 42 days
-11.3%
11 Sept 2026 – open
Trough 23 Oct 2026 · not recovered
-10.0%
3 Jun 2024 – 10 Jun 2024
Trough 4 Jun 2024 · recovered in 6 days
-8.3%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
33
Vs category
44
Consistency
2
Risk-adjusted
47
Drawdown
38
Mean
33
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
No status reasons yet. History is still thin.
Supporting reads
No supporting reads in the current evidence set.
30 Sept 2026 · 63 holdings · top 10 are 30.0%.
Karur Vysya Bank Ltd
Financial
3.6%
Multi Commodity Exchange Of India Ltd
Financial
3.4%
Others CBLO
Unspecified
3.4%
Laurus Labs Ltd
Healthcare
3.2%
Navin Fluorine International Ltd
Materials
3.1%
DECISION
Status moved from MONITOR to HEALTHY.
27 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
21 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
19 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
16 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
24 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Sept 2026
DECISION
Status moved from REVIEW to MONITOR.
22 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
21 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
18 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
17 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
16 Sept 2026